Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
The Journal of Clinical Investigation
|
March 8, 2019
Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination
Eléna Gonçalves, Olivia Bonduelle, Angèle Soria, et al.
Plos One
|
December 1, 2018
HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates
Anne-Laure Flamar, Henri Bonnabau, Sandra Zurawski, et al.
AIDS (London, England)
|
October 17, 2018
Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial
Romain Palich, Jade Ghosn, Antoine Chaillon, et al.
AIDS (London, England)
|
May 11, 2010
Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study
, Colette Smith, Caroline A Sabin, et al.
Journal of Virology
|
March 25, 2016
Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates
Roger Le Grand, Nathalie Dereuddre-Bosquet, Stefania Dispinseri, et al.
Plos Medicine
|
November 1, 2011
Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America
Benjamin H Chi, Constantin T Yiannoutsos, Andrew O Westfall, et al.
Eclinicalmedicine
|
December 9, 2024
Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06)
Yves Levy, Christiane Moog, Aurélie Wiedemann, et al.
JAMA
|
April 7, 2011
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis
Jonathan Z Li, Roger Paredes, Heather J Ribaudo, et al.
The Lancet. HIV
|
December 5, 2017
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial
Collins C Iwuji, Joanna Orne-Gliemann, Joseph Larmarange, et al.
The Journal of Infectious Diseases
|
August 15, 2018
Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV
Felicity C Fitzgerald, Edouard Lhomme, Kathryn Harris, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
The Journal of Clinical Investigation
|
March 8, 2019
Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination
Eléna Gonçalves, Olivia Bonduelle, Angèle Soria, et al.
Plos One
|
December 1, 2018
HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates
Anne-Laure Flamar, Henri Bonnabau, Sandra Zurawski, et al.
AIDS (London, England)
|
October 17, 2018
Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial
Romain Palich, Jade Ghosn, Antoine Chaillon, et al.
AIDS (London, England)
|
May 11, 2010
Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study
, Colette Smith, Caroline A Sabin, et al.
Journal of Virology
|
March 25, 2016
Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates
Roger Le Grand, Nathalie Dereuddre-Bosquet, Stefania Dispinseri, et al.
Plos Medicine
|
November 1, 2011
Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America
Benjamin H Chi, Constantin T Yiannoutsos, Andrew O Westfall, et al.
Eclinicalmedicine
|
December 9, 2024
Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06)
Yves Levy, Christiane Moog, Aurélie Wiedemann, et al.
JAMA
|
April 7, 2011
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis
Jonathan Z Li, Roger Paredes, Heather J Ribaudo, et al.
The Lancet. HIV
|
December 5, 2017
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial
Collins C Iwuji, Joanna Orne-Gliemann, Joseph Larmarange, et al.
The Journal of Infectious Diseases
|
August 15, 2018
Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV
Felicity C Fitzgerald, Edouard Lhomme, Kathryn Harris, et al.
Page
of 6